EA200401289A1 - Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения - Google Patents

Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения

Info

Publication number
EA200401289A1
EA200401289A1 EA200401289A EA200401289A EA200401289A1 EA 200401289 A1 EA200401289 A1 EA 200401289A1 EA 200401289 A EA200401289 A EA 200401289A EA 200401289 A EA200401289 A EA 200401289A EA 200401289 A1 EA200401289 A1 EA 200401289A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
pharmaceutical compositions
compositions containing
connections
production
Prior art date
Application number
EA200401289A
Other languages
English (en)
Inventor
Брадж Бхушан Лохрай
Видья Бхушан Лохрай
Бриджеш Кумар Сривастава
Original Assignee
Кадила Хелзкэр Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кадила Хелзкэр Лимитед filed Critical Кадила Хелзкэр Лимитед
Publication of EA200401289A1 publication Critical patent/EA200401289A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Настоящее изобретение относится к новым противоинфекционным соединениям, к способам их получения и к фармацевтическим композициям, содержащим указанные соединения.Отчет о международном поиске был опубликован 2003.11.13.
EA200401289A 2002-04-01 2003-03-26 Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения EA200401289A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN310MU2002 2002-04-01
PCT/IN2003/000081 WO2003082864A2 (en) 2002-04-01 2003-03-26 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
EA200401289A1 true EA200401289A1 (ru) 2005-04-28

Family

ID=28460710

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401289A EA200401289A1 (ru) 2002-04-01 2003-03-26 Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения

Country Status (8)

Country Link
US (1) US20060229316A1 (ru)
EP (1) EP1495021A2 (ru)
AU (1) AU2003231920A1 (ru)
BR (1) BR0308837A (ru)
CA (1) CA2478502A1 (ru)
EA (1) EA200401289A1 (ru)
WO (1) WO2003082864A2 (ru)
ZA (1) ZA200406844B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513416A1 (en) * 2002-08-22 2004-03-04 Orchid Chemicals & Pharmaceuticals Ltd. Novel antibacterial agents
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20080139574A1 (en) * 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
RU2478619C2 (ru) 2006-12-11 2013-04-10 Ривайва Фармасьютикалс, Инк. Композиции, синтез и способы применения ингибиторов холинэстеразы на основе инданона
WO2008148851A1 (en) 2007-06-08 2008-12-11 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
PE20090362A1 (es) 2007-06-08 2009-04-04 Janssen Pharmaceutica Nv Derivados de piperidina/piperazina como moduladores de dgat
JP5443342B2 (ja) 2007-06-08 2014-03-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピペリジン／ピペラジン誘導体
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
CA2692255A1 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use
WO2009147170A2 (en) 2008-06-05 2009-12-10 Janssen Pharmaceutica Nv Drug combinations comprising a dgat inhibitor and a ppar-agonist
FR3123565A1 (fr) * 2021-06-04 2022-12-09 Institut Des Sciences Et Industries Du Vivant Et De L'environnement - Agroparistech Nouvelles molecules derivees de furanacrylates et 5-hydroxymethyl furanacrylates presentant des proprietes filtre uv-b et/ou antimicrobiennes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
GB9614236D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
BR9910971A (pt) * 1998-06-05 2001-02-13 Astrazeneca Ab Composto, processos para a preparação de um composto e para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto, e, composição farmacêutica
US20010047004A1 (en) * 2000-02-10 2001-11-29 Hester Jackson B. Oxazolidinone thioamides with piperazine amide substituents
US6642238B2 (en) * 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
NZ523700A (en) * 2000-07-17 2004-11-26 Ranbaxy Lab Ltd Oxazolidinone derivatives as antimicrobials
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives

Also Published As

Publication number Publication date
BR0308837A (pt) 2005-02-01
AU2003231920A8 (en) 2003-10-13
EP1495021A2 (en) 2005-01-12
WO2003082864A2 (en) 2003-10-09
CA2478502A1 (en) 2003-10-09
WO2003082864A3 (en) 2003-11-13
ZA200406844B (en) 2006-05-31
US20060229316A1 (en) 2006-10-12
AU2003231920A1 (en) 2003-10-13

Similar Documents

Publication Publication Date Title
EA200200940A1 (ru) Производные азетидина, способ их получения и содержащие их фармацевтические композиции
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
SE0203713D0 (sv) Novel compounds
EA200700255A1 (ru) Новый карбамилированный еро и способ его получения
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
SE0301372D0 (sv) Novel compounds
TW200519075A (en) Novel compounds
SE0301373D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
TW200510301A (en) Novel compounds
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
SE0303180D0 (sv) Novel compounds
CY1105387T1 (el) Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
EA200401526A1 (ru) Новые соединения и их применение
EA200200912A1 (ru) Новые производные индолин-2-она, их получение и их применение в качестве лигандов рецепторов окситоцина
CY1105039T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ
EA200601608A1 (ru) Способ производства твёрдой фармацевтической композиции
EA200800393A1 (ru) Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат
EA200300062A1 (ru) Производные аминоалкилбензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
EA200601217A1 (ru) Новые конденсированные пирролокарбазолы
EA200401289A1 (ru) Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина